 BOSTON and JERUSALEM, March 03, 2022 GLOBE NEWSWIRE -- Entera Bio Ltd. NASDAQ: ENTX, a leader in the development of orally delivered large molecule therapeutics, announced today it will report business and financial results for the 12 months ended December 31, 2021 on Tuesday, March 8, 2022 at 6:30 AM EST. 